0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Rapidly Progressive Glomerulonephritis Treated With Anticoagulants

Allen I. Arieff, MD; Wulf F. Pinggera, MD
Arch Intern Med. 1972;129(1):77-84. doi:10.1001/archinte.1972.00320010081009.
Text Size: A A A
Published online

Rapidly progressive glomerulonephritis (RPGN) was diagnosed in six patients on the basis of the clinical course and typical pathological features on renal biopsy. These patients were given heparin sodium intravenously; when their renal function had stabilized, four patients were then given anticoagulant and antithrombotic agents orally. The administration of heparin was associated with increases in urine output and creatinine clearance in five patients; the orally administered agents resulted in additional improvement of renal function in three of four patients. All patients suffered hemorrhagic complications; one died and another became functionally anephric. Immunofluorescent studies revealed three different deposition patterns. The presence of fibrinogen deposition in glomeruli did not correlate with response to anticoagulant therapy. Anticoagulant and antithrombotic therapy appears to arrest and partially reverse the course of RPGN in most patients, although hemorrhagic complications are frequent.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();